September 24, 2017 7:44 PM ET


Company Overview of Pelias Biomedizinische Entwicklungs AG

Company Overview

Pelias Biomedizinische Entwicklungs AG, a biotechnology company, develops treatments against hospital-acquired infections. The company’s programs include preventive and therapeutic vaccines, as well as therapeutic antibodies targeting common pathogens that cause serious or life-threatening infections acquired during hospitalization. It focuses on pathogens causing hospital-acquired infections, such as Pseudomonas, Klebsiella, and Enterococcus. The company was founded in 2005 and is based in Vienna, Austria. As of January 2, 2007, Pelias Biomedizinische Entwicklungs AG is a subsidiary of Intercell Biomedical Research & Development AG.

Dannebergplatz 16/2

Vienna,  1030


Founded in 2005


43 1 718 03 26


43 1 718 03 26 - 800

Key Executives for Pelias Biomedizinische Entwicklungs AG

Chief Executive Officer and Founding Partner
Director of Clinical Development
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Activartis Biotech GmbH Europe
APEIRON Biologics AG Europe
Apeptico Forschung und Entwicklung GmbH Europe
Aposcience AG Europe
ARTMA Medical Technologies AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Pelias Biomedizinische Entwicklungs AG, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at